Join us for this brand new study day run by international experts in the field. Delegates will gain knowledge of the practicalities of setting up an adaptive radiotherapy service and gain a foundation of the skills and knowledge required by radiotherapy teams in setting up a service.

 

Case based presentations and interactive sessions describing:

  • Evidence base for adaptation
  • Current and future adaptive radiotherapy strategies
  • Resources needed

  • Radiotherapy radiographers
  • Doctors
  • Physicists
  • Students
  • Radiotherapy service managers

Submit your 250 word abstract to by 21 August on your adaptive radiotherapy experience to secure the reduced rate.

Send to education.events@christie.nhs.uk

This event is supported by the below companies. They have had no input into the agenda or selection of topics or speakers.

Gold sponsors

Silver sponsors

 

About Elekta

For almost 5 decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalised radiotherapy treatments.

Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter, Facebook and LinkedIn. 

Elekta Unity

Elekta Unity is a state-of-the art MR-Linac that is defining a new standard for personalised radiation therapy based on real-time high resolution anatomical and biological MRI at the point-of-care. Unity combines a Philips high-field 1.5T MRI scanner with a best-in-class 7MV linear accelerator and breakthrough online dose replanning software that are fully integrated to enable adaptive radiotherapy and real-time target monitoring. 

Elekta Linear Accelerator Solutions

A pioneer in precision radiation medicine, Elekta develops and supports a range of advanced linear accelerators (linacs) that enable physicians to deliver precise, rapid and patient-specific radiotherapy for individuals with cancer. Elekta’s line of high definition digital accelerators includes the latest generation Versa HD™ – a system designed to treat a spectrum of tumors throughout the body using both conventional and highly sophisticated techniques – as well as the clinically-proven and widely used Elekta Synergy® and Elekta Infinity™ linacs.

A special thank you 

Click here to be kept up to date with this and future events https://www.surveymonkey.co.uk/r/mailinglistsignup

Last updated: August 2021